COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network

J Thorac Cardiovasc Surg. 2020 Aug;160(2):601-605. doi: 10.1016/j.jtcvs.2020.03.061. Epub 2020 Apr 9.

Abstract

The extraordinary demands of managing the COVID-19 pandemic has disrupted the world's ability to care for patients with thoracic malignancies. As a hospital's COVID-19 population increases and hospital resources are depleted, the ability to provide surgical care is progressively restricted, forcing surgeons to prioritize among their cancer populations. Representatives from multiple cancer, surgical, and research organizations have come together to provide a guide for triaging patients with thoracic malignancies as the impact of COVID-19 evolves as each hospital.

Publication types

  • Practice Guideline

MeSH terms

  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Clinical Decision-Making
  • Consensus
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Delivery of Health Care, Integrated / organization & administration*
  • Health Services Needs and Demand / organization & administration
  • Host Microbial Interactions
  • Humans
  • Needs Assessment / organization & administration
  • Occupational Health
  • Pandemics
  • Patient Safety
  • Patient Selection
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / transmission
  • Pneumonia, Viral / virology
  • Risk Assessment
  • Risk Factors
  • SARS-CoV-2
  • Thoracic Neoplasms / epidemiology
  • Thoracic Neoplasms / surgery*
  • Thoracic Surgical Procedures* / adverse effects
  • Time-to-Treatment
  • Triage / organization & administration*